Other Income & Expense
Change in AP
Amgen Change in AP decreased by 3.1% to $571.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 14.9%, from $497.00M to $571.00M. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementIncome Statement
SectionOther Income & Expense
CategoryLiquidity
SignalHigher is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026Apr 30, 2026
How to read this metric
An increase suggests the company is effectively using supplier credit to manage cash flow, while a decrease indicates faster payment of liabilities.
Detailed definition
Represents the net change in obligations to suppliers for goods and services received but not yet paid for. It is a crit...
Peer comparison
Standard working capital metric; compared against days payable outstanding (DPO) at peer firms.
Metric ID:
ms_change_in_accounts_payableHistorical Data
14 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q1 '25 | Q2 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$127.00M | -$104.00M | $42.00M | -$140.00M | -$44.00M | $296.00M | -$253.00M | -$118.00M | -$187.00M | $23.00M | $643.00M | $497.00M | $589.00M | $571.00M |
| QoQ Change | — | +18.1% | +140.4% | -433.3% | +68.6% | +772.7% | -185.5% | +53.4% | -58.5% | +112.3% | >999% | -22.7% | +18.5% | -3.1% |
| YoY Change | — | — | — | -10.2% | +57.7% | — | -702.4% | +15.7% | -163.2% | +109.1% | +644.9% | >999% | -8.4% | +14.9% |
Range-$253.00M – $643.00M
CAGR+58.8%
Avg YoY Growth+201.9%
Median YoY Growth+15.3%
Change in AP at Other Companies
Frequently Asked Questions
- What is Amgen's change in ap?
- Amgen (AMGN) reported change in ap of $571.00M in Q1 2026.
- How has Amgen's change in ap changed year-over-year?
- Amgen's change in ap increased by 14.9% year-over-year, from $497.00M to $571.00M.
- What does change in ap mean?
- The change in money the company owes to its suppliers.